Oragenics Earnings Calls

Mar 31, 2026
-$0.510 (99.43%)
Release date May 08, 2026
EPS estimate -$90.00
EPS actual -$0.510
EPS Surprise 99.43%
Revenue estimate -
Revenue actual -
Dec 31, 2025
-$0.540 (99.40%)
Release date Feb 26, 2026
EPS estimate -$90.00
EPS actual -$0.540
EPS Surprise 99.40%
Revenue estimate -
Revenue actual -
Sep 30, 2025
Release date Nov 07, 2025
EPS estimate -
EPS actual -$1.96
Revenue estimate -
Revenue actual -
Jun 30, 2025
Release date Aug 08, 2025
EPS estimate -
EPS actual -$3.10
Revenue estimate -
Revenue actual -

Last 4 Quarters for Oragenics

Below you can see how OGEN performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Jun 30, 2025
Release date Aug 08, 2025
Price on release $1.16
EPS estimate -
EPS actual -$3.10
Date Price
Aug 04, 2025 $1.26
Aug 05, 2025 $1.32
Aug 06, 2025 $1.31
Aug 07, 2025 $1.30
Aug 08, 2025 $1.16
Aug 11, 2025 $1.17
Aug 12, 2025 $1.17
Aug 13, 2025 $1.15
Aug 14, 2025 $1.19
4 days before -7.94%
4 days after 2.59%
On release day 0.86%
Change in period -5.56%
Sep 30, 2025
Release date Nov 07, 2025
Price on release $1.11
EPS estimate -
EPS actual -$1.96
Date Price
Nov 03, 2025 $1.22
Nov 04, 2025 $1.11
Nov 05, 2025 $1.14
Nov 06, 2025 $1.12
Nov 07, 2025 $1.11
Nov 10, 2025 $1.12
Nov 11, 2025 $1.13
Nov 12, 2025 $1.19
Nov 13, 2025 $1.14
4 days before -9.43%
4 days after 3.17%
On release day 1.36%
Change in period -6.56%
Dec 31, 2025 Beat
Release date Feb 26, 2026
Price on release $0.88
EPS estimate -$90.00
EPS actual -$0.540
EPS surprise 99.40%
Date Price
Feb 20, 2026 $0.689
Feb 23, 2026 $0.647
Feb 24, 2026 $0.706
Feb 25, 2026 $0.792
Feb 26, 2026 $0.88
Feb 27, 2026 $0.84
Mar 02, 2026 $0.83
Mar 03, 2026 $0.83
Mar 04, 2026 $0.86
4 days before 27.66%
4 days after -2.11%
On release day -4.52%
Change in period 24.96%
Mar 31, 2026 Beat
Release date May 08, 2026
Price on release $0.597
EPS estimate -$90.00
EPS actual -$0.510
EPS surprise 99.43%
Date Price
May 04, 2026 $0.618
May 05, 2026 $0.639
May 06, 2026 $0.620
May 07, 2026 $0.613
May 08, 2026 $0.597
May 11, 2026 $0.558
May 12, 2026 $0.588
May 13, 2026 $0.570
May 14, 2026 $0.571
4 days before -3.41%
4 days after -4.41%
On release day -6.60%
Change in period -7.67%

Oragenics Earnings History

Earnings Calendar

FAQ

When is the earnings report for OGEN?
Oragenics Inc (OGEN) has scheduled its earnings report for Aug 11, 2026 after the markets close.

What is the OGEN price-to-earnings (P/E) ratio?
OGEN P/E ratio as of Jun 03, 2026 (TTM) is -0.267.

What is the OGEN EPS forecast?
The forecasted EPS (Earnings Per Share) for Oragenics Inc (OGEN) for the first fiscal quarter 2026 is -$72.00.

What are Oragenics Inc's retained earnings?
On its balance sheet, Oragenics Inc reported retained earnings of $0 for the latest quarter ending Mar 31, 2026.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT ORAGENICS INC
Oragenics
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also ...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE